Pfizer (PFE) 21.04 -0.09

Pfizer, Inc.
(PFE) 21.04 -0.09

Last Trade:	21.05	Day Range:	20.90 - 21.06
Trade Time:	04:02PM	52wk Range:	16.63 - 22.17
Prev. Close:	21.14	Market Cap:	161.81B
Open:	21.00	Div Yield:	3.8
Volume:	26910335	PE:	190
EPS:	1.11

The Latest On PFE

Grandpa's 2012 ETF Portfolio 2/10/12 1:48pm

S&P Futures & Big 10 Analysis - Week of Feb 6, 2012 2/6/12 11:19am

Pfizer Issues Statement On Voluntary Recall 2/1/12 4:26pm

S&P Futures & Big 10 Analysis - Week of Jan 30th, 2012 1/31/12 4:10pm

Markets Push Higher on Greek Debt Progress; S&P 500 Tests 1315 Resistance 1/31/12 12:12pm

Earnings Roundup 1/31/12 8:42am

UPDATE: Pfizer Reports Upbeat Q4 Profit, Lowers 2012 Forecast 1/31/12 7:51am

Financial Breakfast: Morning News Summary for January 31, 2012 1/31/12 7:24am

US Stock Futures Signal Higher Start On Wall Street 1/31/12 6:11am

Earnings Scheduled For January 31 1/31/12 3:17am

Stocks To Watch For January 31 1/31/12 2:51am

KineMed Announces Research Collaboration With Pfizer for the Advancement of Novel Approaches in Metabolic Disease 1/30/12 8:14am

Grandpa's 2012 ETF Portfolio 2/10/12

S&P Futures & Big 10 Analysis - Week of Feb 6, 2012 2/6/12

Pfizer Issues Statement On Voluntary Recall 2/1/12

S&P Futures & Big 10 Analysis - Week of Jan 30th, 2012 1/31/12

Markets Push Higher on Greek Debt Progress; S&P 500 Tests 1315 Resistance 1/31/12

Earnings Roundup 1/31/12

UPDATE: Pfizer Reports Upbeat Q4 Profit, Lowers 2012 Forecast 1/31/12

Financial Breakfast: Morning News Summary for January 31, 2012 1/31/12

US Stock Futures Signal Higher Start On Wall Street 1/31/12

Earnings Scheduled For January 31 1/31/12

Stocks To Watch For January 31 1/31/12

KineMed Announces Research Collaboration With Pfizer for the Advancement of Novel Approaches in Metabolic Disease 1/30/12

Grandpa's 2012 ETF Portfolio 2/10/12

S&P Futures & Big 10 Analysis - Week of Feb 6, 2012 2/6/12

S&P Futures & Big 10 Analysis - Week of Jan 30th, 2012 1/31/12

Markets Push Higher on Greek Debt Progress; S&P 500 Tests 1315 Resistance 1/31/12

Financial Breakfast: Morning News Summary for January 31, 2012 1/31/12

Stocks To Watch For January 31 1/31/12

Earnings Expectations for the Week of January 30 1/29/12

What's the Future Like For Health Care? 1/20/12

Financial Breakfast: Morning News Summary for January 17, 2012 1/17/12

How to Trade Biotechs Based on the JP Morgan Health Care Conference 1/11/12

Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? 1/10/12

Did John 3:16 Predict These Companies' Successes? 1/9/12

Financial Breakfast: Morning News Summary for January 31, 2012 1/31/12

Financial Breakfast: Morning News Summary for January 17, 2012 1/17/12

UPDATE: Deutsche Bank Raises PT to $25, Reiterates Buy on Pfizer 1/17/12

How to Trade Biotechs Based on the JP Morgan Health Care Conference 1/11/12

Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? 1/10/12

Bank of America Merrill Lynch Provides Update on Bristol-Myers Squibb 1/4/12

Inside: 2012's Best Value Investment 12/27/11

Financial Breakfast: Morning News Summary for November 30, 2011 11/30/11

Deutsche Bank Reiterates Buy on Pfizer 11/29/11

Canaccord Publishes Report on Specialty Pharmaceuticals 11/28/11

Rodman & Renshaw Maintains Market Outperform on Alnylam Pharma After PFE Acquisition Announcement 11/25/11

Financial Breakfast: Morning News Summary for November 22, 2011 11/22/11

Trade PFE
NOW!

Partner Headlines

Betting On Biotech 2/10/12

Watson Settles Patent Dispute - Analyst Blog 2/10/12

Playing the Momentum Building in Pfizer 2/10/12

Healthy Health Care ETF? 2/9/12

4 IPOs to Watch...and None are Facebook 2/9/12

Forget Big Pharma, It's Time For A Biotech ETF - ETF News And Commentary 2/9/12

Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary 2/9/12

Trading Pfizer 2/9/12

The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer - Press Releases 2/9/12

'Mad Money Lightning Round': Get Some Covidien 2/8/12

Mylan Acquires Two Generics - Analyst Blog 2/8/12

Ten Big Pharma Stocks' Juicy Dividend Payouts, With Cash-on-Hand as Cushion 2/8/12

Press Releases

CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall 2/10/12 Business Wire Story

Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall 2/9/12 Business Wire Story

Pain Therapeutics Reports 2011 Financial Results 2/9/12 GlobeNewswire Story

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen 2/7/12 Newswire Story

St. Louis-based Carey, Danis & Lowe Announces Suit Against the Maker of Zoloft 2/6/12 Business Wire Story

Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall 2/3/12 Business Wire Story

Cardinal Health Introduces Smart-Seal™ Surgical Mask 1/31/12 Newswire Story

Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance 1/31/12 Business Wire Story

KineMed Announces Research Collaboration With Pfizer for the Advancement of Novel Approaches in Metabolic Disease 1/30/12 Business Wire Story

Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's Care 1/27/12 Newswire Story

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer's Care 1/27/12 Business Wire Story

Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease 1/17/12 Business Wire Story

Get the latest PFE stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Pfizer, Inc. stock price.

Pfizer, Inc. by YCharts

Pfizer (PFE) 21.04 -0.09

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On PFE

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social